GENEVA, Nov. 6 -- MEMORIAL SLOAN-KETTERING CANCER CENTER filed a patent application (US2026/026184) for “COMPOSITIONS INCLUDING FCRN INHIBITORS AND METHODS OF USING THE SAME IN IMMUNO-BASED DIAGNOSTICS AND THERAPIES”. With publication no. WO/2026/232015, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G06T 7/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....